Bavarian Nordic A/S revenue for the last year amounted to 791.09 M USD, the most of which — 791.12 M USD — came from its highest performing source at the moment, Life-Saving Vaccines, the year earlier bringing 1.05 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Bavarian Nordic A/S 374.08 M USD, and the year before that — 381.47 M USD.